CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market sale EVP, Operations sold 20,132 shares at $1.27 ($25,568)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.40 ($14,000)
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 100,000 shares at $1.91 ($191,000)
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- 4 Open-market buy Director bought 23,770 shares at $1.76 ($41,835)
- 4 Open-market buy Director bought 50,000 shares at $1.83 ($91,500)
- 4 Open-market buy Director bought 75,000 shares at $1.73 ($129,750)
- 4 Open-market buy Director bought 100,000 shares at $1.71 ($171,000)
- 4 Grant or award Chief Executive Officer acquired 875,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 13 of 65 · 1,296 filings